Compare, Analyse with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ZIM LABORATORIES vs TEVA PHARMA (Israel) - Comparison Results

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ZIM LABORATORIES   TEVA PHARMA
EQUITY SHARE DATA
    ZIM LABORATORIES
Mar-21
TEVA PHARMA
Dec-13
ZIM LABORATORIES/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs1313,101-   
Low Rs532,694-   
Sales per share (Unadj.) Rs189.21,779.9-  
Earnings per share (Unadj.) Rs4.5111.2-  
Cash flow per share (Unadj.) Rs14.2255.1-  
Dividends per share (Unadj.) Rs097.33-  
Avg Dividend yield %03.4 0.0%  
Book value per share (Unadj.) Rs99.01,977.1-  
Shares outstanding (eoy) m16.24848.00-   
Bonus / Rights / Conversions ---  
Price / Sales ratio x0.51.6 29.9%   
Avg P/E ratio x20.526.1 78.5%  
P/CF ratio (eoy) x6.511.4 57.0%  
Price / Book Value ratio x0.91.5 63.5%  
Dividend payout %087.5 0.0%   
Avg Mkt Cap Rs m1,4972,457,250 0.1%   
No. of employees `000NA44.9 0.0%   
Total wages/salary Rs m3580-   
Avg. sales/employee Rs ThNM33,581.7-  
Avg. wages/employee Rs ThNM0-  
Avg. net profit/employee Rs ThNM2,097.8-  
INCOME DATA
Net Sales Rs m3,0731,509,330 0.2%  
Other income Rs m230-   
Total revenues Rs m3,0961,509,330 0.2%   
Gross profit Rs m346413,331 0.1%  
Depreciation Rs m158122,001 0.1%   
Interest Rs m10929,646 0.4%   
Profit before tax Rs m102261,685 0.0%   
Minority Interest Rs m01,189 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-171,782 0.0%   
Tax Rs m29-3,195 -0.9%   
Profit after tax Rs m7394,287 0.1%  
Gross profit margin %11.327.4 41.1%  
Effective tax rate %28.5-1.2 -2,332.6%   
Net profit margin %2.46.2 38.1%  
BALANCE SHEET DATA
Current assets Rs m1,9181,019,396 0.2%   
Current liabilities Rs m1,420889,000 0.2%   
Net working cap to sales %16.28.6 187.3%  
Current ratio x1.41.1 117.7%  
Inventory Days Days1691 17.3%  
Debtors Days Days85896 894.9%  
Net fixed assets Rs m1,304492,981 0.3%   
Share capital Rs m1623,715 4.4%   
"Free" reserves Rs m1,4450-   
Net worth Rs m1,6081,676,580 0.1%   
Long term debt Rs m218771,754 0.0%   
Total assets Rs m3,2223,449,303 0.1%  
Interest coverage x1.99.8 19.7%   
Debt to equity ratio x0.10.5 29.5%  
Sales to assets ratio x1.00.4 217.9%   
Return on assets %5.73.6 157.4%  
Return on equity %4.65.6 80.9%  
Return on capital %11.64.9 234.7%  
Exports to sales %67.40-   
Imports to sales %4.10-   
Net fx Rs m2,0120-   
CASH FLOW
From Operations Rs m319240,509 0.1%  
From Investments Rs m-59-85,222 0.1%  
From Financial Activity Rs m-260-288,507 0.1%  
Net Cashflow Rs m-1-133,220 0.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 74.3 Rs / USD

Compare ZIM LABORATORIES With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  

Compare ZIM LABORATORIES With: DECCAN HEALTH CARE  AMBALAL SARABHAI  TORRENT PHARMA  BIOCON   GLENMARK LIFE SCIENCES  



Today's Market

Sensex Trades Lower, Nifty Near 18,000; Infosys and HCL Tech Top Losers(10:30 am)

Asian stock markets are trading on a negative note today following a Wall Street selloff in the wake of a surge in Treasury yields.

Related Views On News

Sun Pharma vs Dr Reddy's: Which is Better? (Views On News)

Dec 16, 2021

In an extremely competitive market, two pharma companies are competing against each other to grab the top spot.

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

More Views on News

Most Popular

India's Best Semiconductor Stocks Views On News (Views On News)

Jan 7, 2022

Modern wars are fought with semiconductors. India's best semiconductor stocks have big tailwinds from defence and manufacturing.

10 Indian Companies with the Fastest Growth in Dividend Payouts... (Views On News)

Jan 10, 2022

These companies have been consistently paying higher dividends for several years.

Tata Steel vs SAIL: Which Stock is Better? (Views On News)

Jan 13, 2022

With government initiatives set to boost the steel sector, find out who has a better chance of coming out on top.

Looking for Consistent Compounding Stocks? Here's a Watchlist for You (Views On News)

Jan 6, 2022

These companies have generated mind boggling returns for investors over the years.

Watch Out for these 4 Indian Companies Betting Big on EV Supply Chain (Views On News)

Jan 11, 2022

The upside in supply chain players could be huge but a delay in the transition to EVs, or any policy related hiccups could end the momentum.

More
-->

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Free Report: Multibagger Stock Ideas 2022
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: How to Profit from Sensex 100,000
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

ZIM LABORATORIES SHARE PRICE


Jan 19, 2022 12:17 PM

TRACK ZIM LABORATORIES

  • Track your investment in ZIM LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ZIM LABORATORIES

ZIM LABORATORIES 8-QTR ANALYSIS

COMPARE ZIM LABORATORIES WITH

MARKET STATS